Strychnine poisoning leads to seizures that have traditionally been attributed to competitive antagonism of glycine receptors in the spinal cord. Although glycine is thought to act as an inhibitory neurotransmitter, a strychnine-insensitive glytine (Gly,) receptor has been recently described in cultured mouse neurons that is thought to be allosterically linked to the excitatory amino acid NMDA receptor. The present study demonstrates that intrathecally administered glycine, in contrast to other putative inhibitory transmitters, potentiates rather than inhibits strychnine-induced convulsions in mice. The seizure-potentiating effects of glycine are blocked by aminophosphonovaleric acid, an NMDA antagonist.
In addition, in animals pretreated with a subconvulsive dose of strychnine to block strychnine-sensitive glycine receptors (Gly,), glycine enhances, rather than inhibits, NMDA-induced convulsions.
Together, these results indicate that the seizure-potentiating effects of glycine involve activation of NMDA receptors. This study provides the first evidence that glycine is capable of modulating the activity of NMDA receptors in the spinal cords of adult animals. In light of the elevated concentrations of glycine found in epileptogenic brain foci, these data also suggest that glycine may be a positive modulator in the production of epileptic seizures.
Glycine is a simple amino acid and an essential intermediate in many metabolic processes tbroughout the body. Research over the past 2 decades suggests that it is also an important inhibitory neurotransmitter in the CNS (Daly and Aprison, 1983) . Higher concentrations of glycine are found in the spinal cord than in supraspinal regions (Shaw and Heine, 1965; Aprison et al., 1969; Hall et al., 1976; Elekes et al., 1986) . Consistent with its transmitter role, glycine has been localized to presynaptic terminals using both autoradiographic (Ljungdahl and Hbkfelt, 1973) and immunohistochemical approaches (Storm-Mathisen et al., 1986; Clements et al., 1989) . In addition, synaptosomes derived from medulla, spinal cord (Osborne and Bradford, 1973) , and cerebrum (Levi et al., 1982) exhibit a potassium-stimulated, calcium-dependent release of glycine. Further evidence to support glycine's role as an inhibitory transmitter was obtained using electrophysiological approaches that demonstrated gly- Received Nov. 17, 1987; revised Feb. 12, 1988; accepted Mar. 1, 1988 . This work was supported by United States Public Health Service Grants DA04090, DA04190, DE06682, and NS19208 and NSF Grant BNS-8607520.
We wish to express our thanks to Drs. David R. Brown and 110 E. Leppik for their helpful suggestions in the preparation of this manuscript. tine's ability to cause postsynaptic hyperpolarization (Curtis and Watkins, 1960; Werman et al., 1968) by increasing chloride ion conductance (Alger, 1985; Barker, 1985) . Based on strychnine's ability to antagonize glycine (Bradley et al., 1953) , several physiologic roles of glycine have been inferred from symptoms of strychnine poisoning, which is characterized by spinal myoclonus, painful responses to sensory stimulation, and distortion of visual and auditory perceptions (Zarbin et al., 1981) . These effects of strychnine suggest that glycine receptors are important in the function of sensory, motor, and nociceptive pathways.
In association with its putative transmitter role, elevated glytine concentrations are found in human epileptogenic foci removed during surgery for intractable seizures Perry and Hansen, 198 l) , whereas a reduction of glycine content is associated with rigidity (Davidoffet al., 1967; Homma et al., 1979) . The role of glycine in the etiology of epilepsy is especially perplexing as seizures are thought to be associated with excessive excitatory, rather than inhibitory, neuronal activity. It was thus of considerable interest when evidence was presented that 2 glycine receptors exist, the classic strychninesensitive inhibitory site (Gly,) and a newer, strychnine-insensitive site (Gly,) (deFeudis et al., 1978; Kishimoto et al., 1981) . The existence of a Gly, receptor has recently been supported using autoradiographic techniques to differentially localize 3H-glycine and 3H-strychnine binding sites in the CNS (Bristow et al., 1986) and electrophysiological techniques on a cultured murine neuronal preparation (Johnson and Ascher, 1987) . More importantly, this latter in vitro study demonstrated that glycine potentiates the depolarizing effect of N-methyl-D-aspartate (NMDA), one of 3 known types of excitatory amino acid receptors. In order to determine whether Gly, receptors participate in an excitatory effect in vivo and whether this excitation is linked to NMDA receptors in adult animals, we investigated the effect of glycine on the convulsant activity produced by strychnine or NMDA using an exquisitely simple behavioral system in which the effect of drugs can be monitored immediately after their direct injection into the CSF of the spinal cord.
Materials and Methods
Mice weighing between 17 and 25 gm were injected intrathecally (i.t.) following the-method of Hylden aid Wilcox-(1980) as modifikd by Larson (1988) . This method of drue. iniection has been successfullv . , exploited by many investigators to examine the effect of various compounds on nociceptive processing or on convulsant activity. All i.t. injections were made in unanesthetized mice at approximately the L-5, L-6 intervertebral space using a 30-gauge % inch disposable needle on a 50 ~1 luer tip Hamilton syringe. In order to inject different drugs into the same i.t. space, a PElO cannula connecting the 30-gauge needle to the syringe was filled with premeasured 5 ~1 volumes of the drug so- lntrathecal Dose of Glycine @g/injection) Figure I . Effect of glycine on strychnine-and NMDA-induced convulsions in mice. Intrathecal injection of 6 nmol strychnine resulted in seizures lasting 180.6 set (tSEM of 25. I), while injection of 1 nmol NMDA produced convulsions lasting 80.7 set (*SEM of 11.6) in duration. The effects of increasing doses of glycine coadministered with these convulsant compounds are expressed as the percentage of these baseline values. Glycine produced opposite effects on the duration of seizures such that a 55 pg dose of glycine completely inhibited the convulsant effect of NMDA but potentiated the duration of strychnineinduced convulsants to greater than 3 times the control value. Each point represents the mean (tSEM) obtained from at least 6 mice. SEs associated with points on the NMDA curve are quite small and therefore not evident on the graph. The significance (p < 0.00 1) of glycine's effect on the duration of convulsions was determined using a 1 -way ANOVA.
lutions separated by an air bubble. All drugs injected i.t. were dissolved in saline for injection in a 5 ~1 volume. Strvchnine. alvcine. NMDA. taurine, beta-alanine, GABA, and m=aminophbsphondvalericacid (APV) were purchased from Sigma. The duration of convulsive activity was measured as previously described (Beitz and Larson, 1985) .
Results
Injection of 6 nmol(2 pg) of strychnine i.t. in mice produced a convulsive episode beginning within 30 set after injection, which typically persisted intermittently for 3 min. In contrast, i.t. injection of 1 nmol (200 ng) of NMDA produced an immediate, continuous convulsion lasting slightly longer than 1 min. Doses of convulsants were chosen based on their ability to elicit seizures of sufficient duration to enable measurement of inhibition or potentiation of seizure activity. Coadministration of 6 nmol of strychnine with increasing doses of glycine resulted in a marked and dose-related potentiation, rather than inhibition, of the duration of convulsive activity (Fig. 1) . In contrast, coadministration of glycine with 1 nmol NMDA resulted in a dose-related inhibition of seizures. In order to determine the time course of glycine's potentiative effect, 2.4 nmol strychnine was administered at varying times after the i.t. injection of 730 nmol glycine or saline (Fig. 2) . Glycine potentiation of strychnine-induced seizure activity was still evident 4 min after glycine injection.
Intrathecal injection of other putative inhibitory amino acid transmitters at an equimolar dose as glycine (730 nmol) inhibited, rather than potentiated, the duration of strychnine-induced seizures (Fig. 3A) . When administered alone at this dose, betaalanine and taurine caused paralysis, which may simply mask the manifestation of convulsive activity. In contrast to glycine, subparalytic doses of beta-alanine (337 nmol) and taurine (120 nmol) failed to alter the duration of strychnine-induced convulsions (Fig. 3B) . antagonism by a subconvulsive dose of strychnine would be expected to unmask an excitatory effect of glycine at the NMDA-linked Gly, receptor. This was tested by pretreatment of mice with either saline or 0.3 nmol strychnine followed 30 set later by the injection of either 1.36 nmol NMDA alone or NMDA plus 730 nmol glycine. For these injections, the 30-gauge needle was attached to the microsyringe via a PE 10 cannula filled with the appropriate drugs. This allows the sequential injection of 2 different drug solutions into the same intrathecal site rather than requiring 2 separate injections. The convulsive response to i.t. NMDA alone was not altered by strychnine pretreatment (Fig. 4) . In addition, administration of glycine 30 set after this subconvulsive dose of strychnine failed to elicit seizures. Following strychnine administration, however, glycine potentiated, rather than inhibited, NMDA-induced convulsions (Fig. 4) .
In order to further examine whether glycine potentiation of strychnine-induced convulsions is associated with NMDA activity, this potentiation was measured in the presence of APV, a selective antagonist at the NMDA excitatory amino acid receptor (Watkins and Olverman, 1987) . While glycine was again found to potentiate strychnine-induced seizures, coadministration of 1 nmol APV blocked this facilitation (Fig. 5) . The same dose of APV, on the other hand, had no effect on strychnineinduced seizures.
Discussion
Our results are consistent with the existence of 2 glycine receptor subtypes, a strychnine-sensitive and a strychnine-insensitive subtype. While the hypothesis that there are 2 glycine receptors is not new, the suggestion that the Gly, receptor is associated with excitatory, rather than inhibitory, effects has only recently been postulated by Johnson and Ascher (1987) based on their work with cultured embryonic mouse neurons. Our results extend their findings by demonstrating, for the first time, an in vivo excitatory effect of the Gly, receptor in adult animals. Based on data obtained from electrophysiological studies, Johnson and Ascher (1987) proposed an allosteric effect of glycine at the NMDA receptor. Recent binding studies have strengthened this hypothesis by demonstrating that glycine modulates 3H-MK-801 and )H-TCP binding to the NMDA receptor complex in adult rat brain homogenates (Bonhaus et al., 1987; Wong et al., 1987) . In the present study, we demonstrate that glycine's potentiation of strychnine-induced convulsions is, in fact, associated with NMDA activity as this potentiation was inhibited by APV, a selective antagonist at the NMDA excitatory amino acid receptor (Watkins and Olverman, 1987) . The same dose of APV, on the other hand, had no effect on strychnine-induced seizures. This demonstrates that the Gly, response is mediated by activation of an NMDA receptor. These data also suggest that the NMDA modulatory site does not appear to be saturated with interstitial glycine in the spinal cord as exogenous glycine was effective. Thus, the consequence of changes in glycine concentrations or, alternatively, changes in the density of Gly, receptors may play a role in epileptic Figure 4 . Blockade of strychnine-sensitive glycine receptors (Gly,) unmasks an excitatory effect of glycine (Gly,) on NMDA-induced convulsions. All mice were prepared for repeated injections by intrathecally implanting a 30-gauge needle connected by polyethyene tubing to a 50 ~1 Hamilton syringe. Mice were injected with either saline or a subconvulsive dose of strychnine (0.3 nmol) and 30 set later challenged with NMDA (1.36 nmol) or NMDA plus glycine (730 nmol). Glycine alone failed to elicit convulsions in 5 strychnine-pretreated mice (data not shown). Shown above, strychnine pretreatment had no effect on the duration of NMDA-induced seizures. Although glycine had an inhibitory effect on the duration of NMDA-induced seizures in saline-pretreated animals, it had a potentiating effect in strychnine-pretreated mice. Asterisks indicate significant changes in the mean duration of seizures induced by glycine compared with the effect of NMDA in salinepretreated mice. Each bar represents the mean (*SEM) value obtained from 5 animals. Significance was determined using ANOVA followed by Tukey's multiple-comparison procedure (p < 0.0 1).
conditions. The concentration ofglycine in the extracellular fluid ofrat spinal cord has recently been found to be 13.19 PM (Skilling et al., 1988) . The actual concentration of glycine in the area of its receptors, however, as well as the concentration achieved after the i.t. injection of this amino acid are both unknown. Thus, the concentration of glycine necessary to activate the Gly, receptor in vivo in both normal and pathological states remains to be determined. The synergism between the NMDA and Gly, receptors may be important both physiologically and in certain clinical disorders. The observation that pretreatment with glycine potentiates strychnine-induced seizures for several minutes (Fig. 2) in combination with the finding that this facilitation is mediated by NMDA suggests that glycine may produce a long-term enhancement of excitatory amino acid transmission in the CNS. Indeed, spinal neurons grown in a medium containing 0.4 mM glycine differed from spinal neurons grown in a glycine-free medium by an increased paroxysmal excitatory neuronal activity (Nelson et al., 1977) .
Synergistic interactions between glycine and excitatory amino acids may be predicted in certain brain areas based on the marked similarity in distribution of NMDA binding sites and Gly, binding sites compared with the distribution of tritiated strychnine binding sites (Cotman et al., 1987) . There are, in fact, no apparent 3H-strychnine binding sites in the cerebral cortex, hippocampus, and striatum, which contain the highest concentrations of Gly, binding sites (Bristow et al., 1986) . This differential distribution of 2 types of glycine binding sites may have importan implications in the etiology or pathology of epilepsy where glycine concentrations are elevated Perry and Hansen, 198 1) . Glycine is also elevated in the chronic epileptogenic focus in animals with cobalt-induced seizures Figure 5 . Inhibition of glycine's excitatory effect by APV, an NMDA antagonist. Coadministration of dl-amino-phosphonovaleric acid (APV); (1 nmol), an NMDA-type excitatory amino acid receptor antagonist, with strychnine (6 nmol) had no effect on the duration of strychnineinduced convulsions. However, APV completely blocked the glycineinduced potentiation of strychnine-induced seizures, suggesting that nlvcine's notentiating effect is linked to NMDA receptors. Each bar represents the mean CkSEM) duration of seizure activity, and the value at the base of each bar represents the number of mice tested. Significance was determined by ANOVA followed by Tukey's multiple-comparison procedure Qr < 0.01). (vanGelder and Courtois, 1972) . The presense of Gly, receptors in brain areas implicated in epilepsy would provide a mechanism whereby glycine may enhance the generation and propagation of seizure activity.
The potentiation of strychnine appears to be specific for glytine as other putative inhibitory transmitter compounds inhibit, rather than prolong, the duration of strychnine-induced seizures. We have previously shown that GABA inhibits picrotoxin-and bicuculline-induced convulsions (Beitz and Larson, 1985) , which is consistent with a mechanism involving competitive inhibition of an inhibitory receptor. Our present results showing potentiation by glycine of strychnine-induced convulsions are thus in distinct contrast to the interactions between GABA and convulsant compounds that are thought to interact at the GABA receptor. The ability of taurine and beta-alanine to inhibit )Hstrychnine binding, as indicated by their IC,, values, is almost identical to that ofglycine (Marvizon et al., 1986) . Alternatively, the inhibitory effect of beta-alanine, taurine, and GABA on strychnine-induced seizures may be produced by an interaction ofthese compounds with their own inhibitory receptors (McBride and Frederickson, 1980; Yarbrough et al., 198 1) as they display a relatively low ability or are unable to displace strychnineinsensitive )H-glycine binding (Bristow and Bowery, 1986) .
This report describes the novel finding that glycine potentiates the convulsive effect of strychnine when injected i.t., indicating that a Gly, receptor is present in the CNS and that interaction of glycine with this receptor leads to excitatory rather than inhibitory effects in viva. These results further demonstrate that the Gly, receptor in the spinal cord may be functionally linked to an NMDA receptor.
